CD274 and plasma cell myeloma: They discovered that co-culturing pDCs with myeloma cells increases CD73, CD274, HDAC6, TLR7/9, or IL3Ra/CD123 gene expression, while reducing the expression of ADAM33, BAD, BAK1, and CASP3 in tumor cells.